Recombinant thrombomodulin ameliorates experimental autoimmune encephalomyelitis by suppressing high mobility group box 1 and inflammatory cytokines

Clinical&Experimental Immunology, EarlyView.

Source: Clinical and Experimental Immunology - March 26, 2018 Category: Allergy & Immunology Source Type: research